Salubris: SAL0139 drug clinical trial application accepted
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Salubris (002294.SZ) announced that the company has received the acceptance notice issued by the National Medical Products Administration. The clinical trial application for the company's independently developed innovative small molecule drug SAL0139 (project code: SAL0139) has been accepted. The announcement shows that SAL0139 is a small molecule drug with independent intellectual property rights held by the company, and the application submitted this time is for the clinical trial of SAL0139 for the treatment of hyperlipidemia